Ketamine in Adolescents With Treatment-Resistant Depression
Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
This study will test the use of ketamine for treatment of depression in adolescents that have
not responded to other treatments. We will also examine neurobiological mechanisms of
treatment.
Phase:
Phase 2
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute